InflaRx (NASDAQ: IFRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $8.00 price target on the stock.
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update [Yahoo! Finance]
InflaRx Reports First Quarter 2024 Financial Results and Provides Business Update
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024 [Yahoo! Finance]
InflaRx to Host Virtual R&D Event on June 5, 2024 and Report First Quarter 2024 Results on May 8, 2024